Você pesquisou por y - Revista Brasileira de Ginecologia e Obstetrícia
You searched for:"Marco Aurélio Pinho de Oliveira"
We found (6) results for your search.Summary
Rev Bras Ginecol Obstet. 2004;26(4):305-309
DOI 10.1590/S0100-72032004000400007
OBJECTIVE: to develop a new preoperative classification of submucous myomas to evaluate the viability and the degree of difficulty of hysteroscopic myomectomy. METHODS: forty-four patients were submitted to hysteroscopic resection of submucous myomas. The possibility of total resection of the myoma, the surgery duration, the fluid deficit, and the incidence of complications were evaluated. The myomas were classified by the Classification of the European Society of Endoscopic Surgery (CESES) and by the classification proposed (CP) by our group, that besides the degree of penetration of the myoma in the myometrium, adds the parameters: extent of the base of the myoma as related to the uterine wall, the size of the myoma in centimeters and its topography at the uterine cavity. For statistical analysis the Fisher test, the Student t test and the analysis of variance were used. Statistic significance was considered when the p-value was smaller than 0.05 in the bicaudal test. RESULTS: in 47 myomas the hysteroscopic surgery was considered complete. There was no significant difference among the three levels (0, 1 and 2) by CESES. By CP, the difference among the number of complete surgeries was significant (p=0.001) between the two levels (groups I and II). The difference between the surgery duration was significant when the two classifications were compared. In relation to the fluid deficit, just CP presented significant differences among the levels (p=0,02). CONCLUSIONS: the proposed classification includes more clues about the difficulties of the hysteroscopic myomectomy than the standard classification. It should be noted that the number of hysteroscopic myomectomies used for that analysis was modest, being interesting to evaluate the performance of the proposed classification in larger series of cases.
Summary
Rev Bras Ginecol Obstet. 2004;26(4):305-309
DOI 10.1590/S0100-72032004000400007
OBJECTIVE: to develop a new preoperative classification of submucous myomas to evaluate the viability and the degree of difficulty of hysteroscopic myomectomy. METHODS: forty-four patients were submitted to hysteroscopic resection of submucous myomas. The possibility of total resection of the myoma, the surgery duration, the fluid deficit, and the incidence of complications were evaluated. The myomas were classified by the Classification of the European Society of Endoscopic Surgery (CESES) and by the classification proposed (CP) by our group, that besides the degree of penetration of the myoma in the myometrium, adds the parameters: extent of the base of the myoma as related to the uterine wall, the size of the myoma in centimeters and its topography at the uterine cavity. For statistical analysis the Fisher test, the Student t test and the analysis of variance were used. Statistic significance was considered when the p-value was smaller than 0.05 in the bicaudal test. RESULTS: in 47 myomas the hysteroscopic surgery was considered complete. There was no significant difference among the three levels (0, 1 and 2) by CESES. By CP, the difference among the number of complete surgeries was significant (p=0.001) between the two levels (groups I and II). The difference between the surgery duration was significant when the two classifications were compared. In relation to the fluid deficit, just CP presented significant differences among the levels (p=0,02). CONCLUSIONS: the proposed classification includes more clues about the difficulties of the hysteroscopic myomectomy than the standard classification. It should be noted that the number of hysteroscopic myomectomies used for that analysis was modest, being interesting to evaluate the performance of the proposed classification in larger series of cases.
Summary
Rev Bras Ginecol Obstet. 2010;32(1):33-38
DOI 10.1590/S0100-72032010000100006
PURPOSE: to describe the clinical signs and symptoms of patients with bone metaplasia and to assess the risk factors for changes in these symptoms after removal of the bone fragment. METHODS: a cross-sectional study was conducted on 16 patients with a diagnosis of bone fragments in the uterine cavity during the period comprising July 2006 to January 2009. The inclusion criterion was the detection of a bone fragment removed from the uterine cavity. The presence of bone tissue in the endometrial cavity was histologically confirmed in all patients. The data of all patients were obtained before and after removal by means of a questionnaire for the evaluation of the effect of removal on the symptoms and for the search of possible factors related to the onset of the disease. RESULTS: half the patients (8/16) had hemorrhagic symptoms and one third (6/16) were infertile. Removal of the fragments was quite effective in improving the complaints, with the disappearance of symptoms in all cases of hemorrhage and of pelvic pain. CONCLUSION: removal of bone fragments can restore the fertility of selected patients whose infertility is caused by bone metaplasia and is quite effective in leading to improvement in patients with pelvic pain and menorrhage.
Summary
Rev Bras Ginecol Obstet. 2010;32(1):33-38
DOI 10.1590/S0100-72032010000100006
PURPOSE: to describe the clinical signs and symptoms of patients with bone metaplasia and to assess the risk factors for changes in these symptoms after removal of the bone fragment. METHODS: a cross-sectional study was conducted on 16 patients with a diagnosis of bone fragments in the uterine cavity during the period comprising July 2006 to January 2009. The inclusion criterion was the detection of a bone fragment removed from the uterine cavity. The presence of bone tissue in the endometrial cavity was histologically confirmed in all patients. The data of all patients were obtained before and after removal by means of a questionnaire for the evaluation of the effect of removal on the symptoms and for the search of possible factors related to the onset of the disease. RESULTS: half the patients (8/16) had hemorrhagic symptoms and one third (6/16) were infertile. Removal of the fragments was quite effective in improving the complaints, with the disappearance of symptoms in all cases of hemorrhage and of pelvic pain. CONCLUSION: removal of bone fragments can restore the fertility of selected patients whose infertility is caused by bone metaplasia and is quite effective in leading to improvement in patients with pelvic pain and menorrhage.
Summary
Rev Bras Ginecol Obstet. 2001;23(6):365-370
DOI 10.1590/S0100-72032001000600004
Purpose: to compare ovarian adhesion according to different types of ovarian cortex closure. Methods: fifteen rabbits were randomly assigned to 3 groups according to the type of ovarian cortex closure, consisting of bipolar diathermy, 5-0 polyglactin 910 and 5-0 plain catgut. After 2 weeks the animals were sacrificed and the adhesion scores were evaluated in the right ovary using the Diamond classification. The left ovary, not incised, was used as control. Statistical analyses were done using analysis of variance (ANOVA), Scheffé test and Student's t test. Results:the mean adhesion scores for the bipolar, polyglactin and plain catgut groups were 0.7, 1.5 and 2.0, respectively. The analysis of variance detected a significant difference (p=0.02) between the three groups. Using Scheffé test for the two by two comparison of the groups, a significant difference was found between the bipolar and the plain catgut groups. Comparing the group in which sutures were used (independent of the material employed) with the bipolar group, a statistically significant difference was observed (1.8 and 0.7, respectively, p=0.01). Conclusions: the results obtained in this study are in accordance with the literature data, showing that second intention closure is more advantageous, concerning adhesion formation, than closure using sutures.
Summary
Rev Bras Ginecol Obstet. 2001;23(6):365-370
DOI 10.1590/S0100-72032001000600004
Purpose: to compare ovarian adhesion according to different types of ovarian cortex closure. Methods: fifteen rabbits were randomly assigned to 3 groups according to the type of ovarian cortex closure, consisting of bipolar diathermy, 5-0 polyglactin 910 and 5-0 plain catgut. After 2 weeks the animals were sacrificed and the adhesion scores were evaluated in the right ovary using the Diamond classification. The left ovary, not incised, was used as control. Statistical analyses were done using analysis of variance (ANOVA), Scheffé test and Student's t test. Results:the mean adhesion scores for the bipolar, polyglactin and plain catgut groups were 0.7, 1.5 and 2.0, respectively. The analysis of variance detected a significant difference (p=0.02) between the three groups. Using Scheffé test for the two by two comparison of the groups, a significant difference was found between the bipolar and the plain catgut groups. Comparing the group in which sutures were used (independent of the material employed) with the bipolar group, a statistically significant difference was observed (1.8 and 0.7, respectively, p=0.01). Conclusions: the results obtained in this study are in accordance with the literature data, showing that second intention closure is more advantageous, concerning adhesion formation, than closure using sutures.
Summary
Rev Bras Ginecol Obstet. 2000;22(8):495-502
DOI 10.1590/S0100-72032000000800005
Purpose: to critically evaluate the histopathologic findings and the cost/benefit relation of dilatation and uterine curettage (D&C) in the evaluation of the abnormal uterine bleeding (AUB). Method: retrospective analysis of the histopathological findings in 542 D&C performed for AUB in the Department of Gynecology of the Faculdade de Ciências Médicas da Universidade do Estado do Rio de Janeiro (FCM-UERJ), between January 1984 and January 1994. The patients were divided into two groups: Group 1 - patients <=50 years (385 D&C) and Group 2 -- patients >50 years (157 D&C). Cases of urgency curettage were excluded from the study. All the curettages were accomplished under narcosis. The mean hospitalization lenght was three days. A histopa-thological finding of proliferative, secretory, atrophic or iatrogenic type endometrium was considered a negative pathological result. The term iatrogenic refers to the endometrium under possible influence of hormonal medication. When the histopathological finding evidenced some lesion, this was considered a positive pathological result. Results: in Group 1 there was a negative pathological result in 50.2% of the cases, positive pathological result in 39.7% of the cases, and insufficient material for diagnosis (IMD) in 10.1% of the cases. Endometrial polyp and submucosal leiomyoma were found in only 5.5% and 4.4%, respectively. Cancer was an uncommon observation in that group, endometrial adenocarcinoma (EAC) (five cases) being found in only 1.3% of the cases, in a relation of 77 D&C to one EAC. In Group 2, a negative pathological result was observed in 38.3% of the cases, positive pathological result in 38.1% of the cases and IMD in 23.6% of the cases. Endometrial polyp and submucosal leiomyoma were found only in 5.1% and 0.6%, respectively. Malignant lesions were found in 12% of the cases EAC being 9.5% (15 cases), showing a relation of one EAC to 10 D&C. Conclusions: according to the current knowledge on the etiology of AUB, this study showed that traditional diagnostic D&C has low accuracy in the evaluation of AUB and a cost/benefit relation incompatible with current medicine. Therefore, it should not be the examination of first choice. Considering, however, that EAC was found in one of each 10 D&C in women >50 years with a complaint of uterine bleeding, D&C can be indicated with more liberality in that group, if hysteroscopy with directed biopsy is not available. Nowadays, D&C does not play such a significant a role in the diagnosis of AUB as it did some years ago. However, the procedure is still indicated in some situations and it cannot be abandoned, and its indication should obey restricted criteria.
Summary
Rev Bras Ginecol Obstet. 2000;22(8):495-502
DOI 10.1590/S0100-72032000000800005
Purpose: to critically evaluate the histopathologic findings and the cost/benefit relation of dilatation and uterine curettage (D&C) in the evaluation of the abnormal uterine bleeding (AUB). Method: retrospective analysis of the histopathological findings in 542 D&C performed for AUB in the Department of Gynecology of the Faculdade de Ciências Médicas da Universidade do Estado do Rio de Janeiro (FCM-UERJ), between January 1984 and January 1994. The patients were divided into two groups: Group 1 - patients <=50 years (385 D&C) and Group 2 -- patients >50 years (157 D&C). Cases of urgency curettage were excluded from the study. All the curettages were accomplished under narcosis. The mean hospitalization lenght was three days. A histopa-thological finding of proliferative, secretory, atrophic or iatrogenic type endometrium was considered a negative pathological result. The term iatrogenic refers to the endometrium under possible influence of hormonal medication. When the histopathological finding evidenced some lesion, this was considered a positive pathological result. Results: in Group 1 there was a negative pathological result in 50.2% of the cases, positive pathological result in 39.7% of the cases, and insufficient material for diagnosis (IMD) in 10.1% of the cases. Endometrial polyp and submucosal leiomyoma were found in only 5.5% and 4.4%, respectively. Cancer was an uncommon observation in that group, endometrial adenocarcinoma (EAC) (five cases) being found in only 1.3% of the cases, in a relation of 77 D&C to one EAC. In Group 2, a negative pathological result was observed in 38.3% of the cases, positive pathological result in 38.1% of the cases and IMD in 23.6% of the cases. Endometrial polyp and submucosal leiomyoma were found only in 5.1% and 0.6%, respectively. Malignant lesions were found in 12% of the cases EAC being 9.5% (15 cases), showing a relation of one EAC to 10 D&C. Conclusions: according to the current knowledge on the etiology of AUB, this study showed that traditional diagnostic D&C has low accuracy in the evaluation of AUB and a cost/benefit relation incompatible with current medicine. Therefore, it should not be the examination of first choice. Considering, however, that EAC was found in one of each 10 D&C in women >50 years with a complaint of uterine bleeding, D&C can be indicated with more liberality in that group, if hysteroscopy with directed biopsy is not available. Nowadays, D&C does not play such a significant a role in the diagnosis of AUB as it did some years ago. However, the procedure is still indicated in some situations and it cannot be abandoned, and its indication should obey restricted criteria.
, , , , , Summary
Rev Bras Ginecol Obstet. 2021;43(10):796-801
, , , , , , , , , , , , , , Summary
Rev Bras Ginecol Obstet. 2021;43(10):796-801
, , , , , , , , , , , , , , 
Summary
Rev Bras Ginecol Obstet. 2022;44(9):891-898
To evaluate the effect of neuromodulatory drugs on the intensity of chronic pelvic pain (CPP) in women.
Searches were carried out in the PubMed, Cochrane Central, Embase, Lilacs, OpenGrey, and Clinical Trials databases.
The searches were carried out by two of the authors, not delimiting publication date or original language. The following descriptors were used: chronic pelvic pain in women OR endometriosis, associated with MESH/ENTREE/DeCS: gabapentinoids, gabapentin, amitriptyline, antidepressant, pregabalin, anticonvulsant, sertraline, duloxetine, nortriptyline, citalopram, imipramine, venlafaxine, neuromodulation drugs, acyclic pelvic pain, serotonin, noradrenaline reuptake inhibitors, and tricyclic antidepressants, with the Boolean operator OR. Case reports and systematic reviews were excluded.
The following data were extracted: author, year of publication, setting, type of study, sample size, intervention details, follow-up time, and results.
A total of 218 articles were found, with 79 being excluded because they were repeated, leaving 139 articles for analysis: 90 were excluded in the analysis of the titles, 37 after reading the abstract, and 4 after reading the articles in full, and 1 could not be found, therefore, leaving 7 articles that were included in the review.
Most of the studies analyzed have shown pain improvement with the help of neuromodulators for chronic pain. However, no improvement was found in the study with the highest statistical power. There is still not enough evidence that neuromodulatory drugs reduce the intensity of pain in women with CPP.
Summary
Rev Bras Ginecol Obstet. 2022;44(9):891-898
To evaluate the effect of neuromodulatory drugs on the intensity of chronic pelvic pain (CPP) in women.
Searches were carried out in the PubMed, Cochrane Central, Embase, Lilacs, OpenGrey, and Clinical Trials databases.
The searches were carried out by two of the authors, not delimiting publication date or original language. The following descriptors were used: chronic pelvic pain in women OR endometriosis, associated with MESH/ENTREE/DeCS: gabapentinoids, gabapentin, amitriptyline, antidepressant, pregabalin, anticonvulsant, sertraline, duloxetine, nortriptyline, citalopram, imipramine, venlafaxine, neuromodulation drugs, acyclic pelvic pain, serotonin, noradrenaline reuptake inhibitors, and tricyclic antidepressants, with the Boolean operator OR. Case reports and systematic reviews were excluded.
The following data were extracted: author, year of publication, setting, type of study, sample size, intervention details, follow-up time, and results.
A total of 218 articles were found, with 79 being excluded because they were repeated, leaving 139 articles for analysis: 90 were excluded in the analysis of the titles, 37 after reading the abstract, and 4 after reading the articles in full, and 1 could not be found, therefore, leaving 7 articles that were included in the review.
Most of the studies analyzed have shown pain improvement with the help of neuromodulators for chronic pain. However, no improvement was found in the study with the highest statistical power. There is still not enough evidence that neuromodulatory drugs reduce the intensity of pain in women with CPP.
